Vân Nguyên-Trân

1.5k total citations
22 papers, 821 citations indexed

About

Vân Nguyên-Trân is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Vân Nguyên-Trân has authored 22 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Vân Nguyên-Trân's work include Diabetes Treatment and Management (7 papers), Neuropeptides and Animal Physiology (7 papers) and Receptor Mechanisms and Signaling (6 papers). Vân Nguyên-Trân is often cited by papers focused on Diabetes Treatment and Management (7 papers), Neuropeptides and Animal Physiology (7 papers) and Receptor Mechanisms and Signaling (6 papers). Vân Nguyên-Trân collaborates with scholars based in United States, Canada and Switzerland. Vân Nguyên-Trân's co-authors include Kenneth R. Chien, Robert B. Clark, Wayne R. Giles, Masahiko Hoshijima, Yusu Gu, Ching‐Feng Cheng, John Ross, Hai-Chien Kuo, Yasuhiro Ikeda and Jim Jung‐Ching Lin and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Vân Nguyên-Trân

22 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vân Nguyên-Trân United States	12	620	314	139	111	67	22	821
Rhonda L. Carter United States	19	627 1.0×	205 0.7×	192 1.4×	122 1.1×	53 0.8×	33	948
Christian Ried Germany	14	772 1.2×	227 0.7×	148 1.1×	232 2.1×	41 0.6×	19	1.1k
Saverio Gentile United States	15	698 1.1×	168 0.5×	143 1.0×	52 0.5×	122 1.8×	34	939
Randal M. Bugianesi United States	15	621 1.0×	209 0.7×	201 1.4×	67 0.6×	17 0.3×	16	773
Nicole Mayer Austria	9	419 0.7×	85 0.3×	75 0.5×	228 2.1×	58 0.9×	13	736
Tomohiro Noguchi Japan	14	614 1.0×	70 0.2×	93 0.7×	42 0.4×	56 0.8×	56	949
S Saheki Japan	7	448 0.7×	245 0.8×	84 0.6×	291 2.6×	42 0.6×	11	736
Caimei Zhang China	14	527 0.8×	438 1.4×	99 0.7×	63 0.6×	15 0.2×	28	918
Charity Duran United States	9	631 1.0×	135 0.4×	249 1.8×	131 1.2×	16 0.2×	11	822
Daniel Potreau France	19	797 1.3×	631 2.0×	317 2.3×	91 0.8×	24 0.4×	54	1.2k

Countries citing papers authored by Vân Nguyên-Trân

Since Specialization

Citations

This map shows the geographic impact of Vân Nguyên-Trân's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vân Nguyên-Trân with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vân Nguyên-Trân more than expected).

Fields of papers citing papers by Vân Nguyên-Trân

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vân Nguyên-Trân. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vân Nguyên-Trân. The network helps show where Vân Nguyên-Trân may publish in the future.

Co-authorship network of co-authors of Vân Nguyên-Trân

This figure shows the co-authorship network connecting the top 25 collaborators of Vân Nguyên-Trân. A scholar is included among the top collaborators of Vân Nguyên-Trân based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vân Nguyên-Trân. Vân Nguyên-Trân is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Shao, Sida, Nan Zhang, Qiangwei Fu, et al.. (2024). Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair. Proceedings of the National Academy of Sciences. 121(16). e2400077121–e2400077121. 10 indexed citations

2.

Yang, Yi‐Fang, et al.. (2022). Design of Potent and Proteolytically Stable Biaryl-Stapled GLP-1R/GIPR Peptide Dual Agonists. ACS Chemical Biology. 17(5). 1249–1258. 6 indexed citations

3.

Shi, Yan, Peng Sang, David Huang, et al.. (2022). α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo. Acta Pharmaceutica Sinica B. 13(4). 1648–1659. 5 indexed citations

4.

Tran, Tuan Anh, Siying Zhu, Seung‐Hyuk Choi, et al.. (2021). A small molecule UPR modulator for diabetes identified by high throughput screening. Acta Pharmaceutica Sinica B. 11(12). 3983–3993. 11 indexed citations

5.

Sang, Peng, Yan Shi, David Huang, et al.. (2020). The activity of sulfono-γ-AApeptide helical foldamers that mimic GLP-1. Science Advances. 6(20). eaaz4988–eaaz4988. 39 indexed citations

6.

Yang, Pengyu, Huafei Zou, David Huang, et al.. (2020). New Generation Oxyntomodulin Peptides with Improved Pharmacokinetic Profiles Exhibit Weight Reducing and Anti-Steatotic Properties in Mice. Bioconjugate Chemistry. 31(4). 1167–1176. 25 indexed citations

7.

Huang, David, Vân Nguyên-Trân, Sean B. Joseph, et al.. (2020). Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity. Journal of Medicinal Chemistry. 63(17). 9660–9671. 19 indexed citations

8.

Lei, Lei, et al.. (2020). Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist. Molecules. 25(11). 2508–2508. 4 indexed citations

9.

Yu, Shan, Huafei Zou, Sean B. Joseph, et al.. (2019). Design of a Long-Acting and Selective MEG-Fatty Acid Stapled Prolactin-Releasing Peptide Analog. ACS Medicinal Chemistry Letters. 10(8). 1166–1172. 12 indexed citations

10.

Huang, Zhihong, Matthew S. Tremblay, Tom Wu, et al.. (2019). Discovery of 5-(3,4-Difluorophenyl)-3-(pyrazol-4-yl)-7-azaindole (GNF3809) for β-Cell Survival in Type 1 Diabetes. ACS Omega. 4(2). 3571–3581. 9 indexed citations

11.

Fu, Qiangwei, et al.. (2019). Engineering a Potent, Long-Acting, and Periphery-Restricted Oxytocin Receptor Agonist with Anorexigenic and Body Weight Reducing Effects. Journal of Medicinal Chemistry. 63(1). 382–390. 7 indexed citations

12.

Wang, Ying, Jintang Du, Huafei Zou, et al.. (2016). Multifunctional Antibody Agonists Targeting Glucagon‐like Peptide‐1, Glucagon, and Glucose‐Dependent Insulinotropic Polypeptide Receptors. Angewandte Chemie. 128(40). 12663–12666. 2 indexed citations

13.

Wang, Rongsheng E., Ying Wang, Yuhan Zhang, et al.. (2016). Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant. Proceedings of the National Academy of Sciences. 113(41). 11501–11506. 25 indexed citations

14.

Wang, Ying, Jintang Du, Huafei Zou, et al.. (2016). Multifunctional Antibody Agonists Targeting Glucagon‐like Peptide‐1, Glucagon, and Glucose‐Dependent Insulinotropic Polypeptide Receptors. Angewandte Chemie International Edition. 55(40). 12475–12478. 17 indexed citations

15.

Azarian, Sassan M., Xue Zhang, Vân Nguyên-Trân, et al.. (2011). A Rapid, Sensitive, Medium-Throughput Assay for Quantitation of Ocular A2E And Visual Cycle Retinoids. Investigative Ophthalmology & Visual Science. 52(14). 3354–3354. 1 indexed citations

16.

Jacobson, Laura H., S. Renee Commerford, Frédérique Chaperon, et al.. (2011). Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(6). 565–581. 6 indexed citations

17.

Kleiner, Sandra, et al.. (2009). PPARδ Agonism Activates Fatty Acid Oxidation via PGC-1α but Does Not Increase Mitochondrial Gene Expression and Function. Journal of Biological Chemistry. 284(28). 18624–18633. 122 indexed citations

18.

Epple, Robert, Mihai Azimioara, Xing Wang, et al.. (2009). Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists. Journal of Medicinal Chemistry. 53(1). 77–105. 36 indexed citations

19.

Kuo, Hai-Chien, Ching‐Feng Cheng, Robert B. Clark, et al.. (2001). A Defect in the Kv Channel-Interacting Protein 2 (KChIP2) Gene Leads to a Complete Loss of Ito and Confers Susceptibility to Ventricular Tachycardia. Cell. 107(6). 801–813. 343 indexed citations

20.

Nguyên-Trân, Vân, Steven W. Kubalak, Susumu Minamisawa, et al.. (2000). A Novel Genetic Pathway for Sudden Cardiac Death via Defects in the Transition between Ventricular and Conduction System Cell Lineages. Cell. 102(5). 671–682. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact